Regulatory Updates

HSA update guidance on medical device product registration GN-15

HSA issues updated guidance on Medical Device Product Registration (GN-15)

The Singapore Health Sciences Authority (HSA) has updated regulatory Guidance GN-15 on Medical Device Product Registration to expand the types of approvals from the following reference regulatory agencies: For Class B Medical Devices, the updated reference agencies’ approval types include: The US Food and Drug Administration (US FDA) De Novo

HSA issues updated guidance on Grouping of Medical Devices for Registration

HSA issues updated guidance on Grouping of Medical Devices for Registration

The Singapore Health Sciences Authority (HSA) has issued updated Guidance on the Grouping of Medical Devices for Registration (GN12-2 revision 2). This concerns:   Dental Medical Devices of Class B only which wish to apply for registration using dental grouping terms. Applicants may group their dental devices using GN-12-1 or

MDA Guideline on Registration of COVID-19 Test Kits

MDA Guideline on Registration of COVID-19 Test Kits

The Malaysian Medical Device Authority (MDA) released a new Guideline for the Registration of COVID-19 IVD Test Kits (MD/GL/07) on 24 January 2022. The guideline covers both the registration of COVID-19 test kits for those kits which have previously obtained Special Access Notification or Conditional Approval. It also covers registration

mda announces end special access routes covid19 test kits

Malaysian MDA announces end of Special Access Route for COVID-19 Test Kits

The Malaysian Medical Devices Authority (MDA) has decided that all COVID-19 test kits whether for professional use or for personal use must be registered under Section 5 of the Medical Devices Act 2012 (Act 737) before being placed on the market. This is effective as of 1 February 2022. This

Draft guidelines categorization of borderline health products FDA Philippines

FDA Philippines issues draft guideline on categorization of borderline health products

The Food and Drug Administration Policy and Planning Service (FDA PPS) of the Philippines has issued draft guidelines for comments and input from industry stakeholders covering the categorization of borderline health products under the jurisdiction of the FDA. The FDA’s jurisdiction covers multiple product categories such as devices, cosmetics, drugs,

Sign up for our regulatory roundup delivered once a month to your inbox

Scroll to Top

Contact Us

Contact Form Demo

Stay Ahead in Southeast Asia's Medical Device Market!

Subscribe to our Newsletter
Be the first to receive essential updates on regulatory changes, market trends, and industry insights from us!

Andaman Medical - Mar Socials 2025 (11)